Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 2618 to 2667 of 3228 in total 
    Value Type: Measured
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cab2. [source:refseq;acc:nm\_033419]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5599.85\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5683\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01485\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 5 (heat shock protein hsp40-3) (heat shock protein cognate 40) (hsc40) (hsp40-2). [source:swissprot;acc:o75953]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 1 (heat shock 40 kda protein 1) (heat shock protein 40) (hsp40) (dnaj protein homolog 1) (hdj-1). [source:swissprot;acc:p25685]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic peptide chain release factor subunit 1 (erf1) (eukaryotic release factor 1) (tb3-1) (c11 protein). [source:swissprot;acc:p46055]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of actin mutations 2-like isoform b; dj1033b10.5. [source:refseq;acc:nm\_022553]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 3 beta 1 subunit (beta-adaptin 3a) (ap-3 complex beta-3a subunit) (beta-3a-adaptin). [source:swissprot;acc:o00203]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6815.24\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6916.14\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01481\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ny-ren-24 antigen (fragment). [source:sptrembl;acc:q9y5a4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 3 beta 2 subunit (beta-adaptin 3b) (ap-3 complex beta-3b subunit) (beta-3b-adaptin) (neuron-specific vesicle coat protein beta-nap). [source:swissprot;acc:q13367]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
insulin gene enhancer protein isl-1 (islet-1). [source:swissprot;acc:p20663]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7424.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7534.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01479\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2627\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-specific protease otubain 1. [source:refseq;acc:nm\_017670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7135.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7240.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0147\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2628\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s9. [source:swissprot;acc:p46781]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3933.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3877.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0146\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2629\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 14.4 kda polypeptide (ec 2.7.7.6) (rpb6) (rpb14.4) (rpabc2). [source:swissprot;acc:p41584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4582.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4649.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01458\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2630\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (62kd). [source:refseq;acc:nm\_006468]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3985.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3928.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
highly expressed in cancer, rich in leucine heptad repeats. [source:refseq;acc:nm\_006101]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4508.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4446.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01403\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2632\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h4. [source:swissprot;acc:p02304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6072.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6155.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01365\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2633\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerases iii 39 kda polypeptide (ec 2.7.7.6) (rna polymerase iii c39 subunit). [source:swissprot;acc:q9h1d9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4000.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3947.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2634\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein p0-like protein; 60s acidic ribosomal protein po; ribosomal protein, large, p0-like. [source:refseq;acc:nm\_016183]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3640.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3688.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01329\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2635\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hiv-1 tat interactive protein 2, 30kda; tat-interacting protein (30kd); hiv-1 tat interactive protein 2, 30 kda; hiv-1 tat interactive protein 2, 30 kd. [source:refseq;acc:nm\_006410]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7197.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7291.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01304\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2636\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba207c16.2 (fragment). [source:sptrembl;acc:q9nql7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7017.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7108.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2637\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase nyd-sp25. [source:refseq;acc:nm\_033516]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6527.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6608.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01242\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2638\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
insulin gene enhancer protein isl-2 (islet-2). [source:swissprot;acc:q96a47]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7433.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7525.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0123\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2639\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trehalase precursor (ec 3.2.1.28) (alpha,alpha-trehalase) (alpha,alpha-trehalose glucohydrolase). [source:swissprot;acc:o43280]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6742.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6814.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01063\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2640\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein nova-1 (neuro-oncological ventral antigen 1) (onconeural ventral antigen-1) (paraneoplastic ri antigen) (ventral neuron-specific protein 1). [source:swissprot;acc:p51513]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5339.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5395.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01052\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2641\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-repair protein complementing xp-g cells (xeroderma pigmentosum group g complementing protein) (dna excision repair protein ercc-5). [source:swissprot;acc:p28715]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3377.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3411.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0102\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2642\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vam6/vps39-like protein (hvam6p). [source:swissprot;acc:q96jc1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5935.71\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5876.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01012\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2643\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein 4 (map 4). [source:swissprot;acc:p27816]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2644\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquilin 1 isoform 1. [source:refseq;acc:nm\_013438]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9125.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9217\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01007\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2645\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin-1 ubiquitin-like interacting protein. [source:refseq;acc:nm\_020131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9128.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9218.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00989\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2646\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mct-1 protein. [source:refseq;acc:nm\_014060]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4778.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4732.13\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00975\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2647\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l22. [source:refseq;acc:nm\_014180]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2648\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor protein d54 (hd54) (d52-like 2). [source:swissprot;acc:o43399]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6365.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6424.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00935\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2649\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
jm4 protein. [source:refseq;acc:nm\_007213]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7133.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7067.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00933\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2650\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beclin 1 (coiled-coil myosin-like bcl2-interacting protein) (protein gt197). [source:swissprot;acc:q14457]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
9150.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9234.09\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00914\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2651\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s protease regulatory subunit 8 (proteasome subunit p45) (thyroid hormone receptor interacting protein 1) (trip1) (msug1 protein) (tat-binding protein homolog 10) (tbp10) (p45/sug). [source:swissprot;acc:p47210]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2652\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor protein d52 (n8 protein). [source:swissprot;acc:p55327]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6349.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6407.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00909\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2653\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor protein d53 (hd53) (d52-like 1). [source:swissprot;acc:q16890]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6349.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6406.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00905\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoskeleton related vitamin a responsive protein; glutamate transporter eeac1-associated protein; dermal papilla derived protein 11; putative mapk activating protein pm27. [source:refseq;acc:nm\_006407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7118.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7055.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0089\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2655\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nf-kappab inhibitor epsilon (nf-kappa-bie) (i-kappa-b-epsilon) (ikappabepsilon) (ikb-epsilon) (ikbe). [source:swissprot;acc:o00221]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8290.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8220.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00861\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2656\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc ribbon domain containing, 1; transcription-associated zinc ribbon protein; rna polymerase i small specific subunit rpa12. [source:refseq;acc:nm\_014596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4191.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4226.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00852\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2657\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 6 (traf4-associated factor 2). [source:swissprot;acc:q9unh7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5327.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5371.47\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00824\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-cell lymphoma 3-encoded protein (bcl-3 protein). [source:swissprot;acc:p20749]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8278.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8211.05\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2659\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor nf-kappa-b p105 subunit (dna-binding factor kbf1) (ebp- 1) [contains: nuclear factor nf-kappa-b p50 subunit]. [source:swissprot;acc:p19838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8277.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8210.29\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00821\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2660\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nf-kappab inhibitor beta (nf-kappa-bib) (i-kappa-b-beta) (ikappabbeta) (ikb-beta) (ikb-b) (thyroid receptor interacting protein 9) (tr- interacting protein 9). [source:swissprot;acc:q15653]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8277.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8210.21\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2661\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor nf-kappa-b p100/p49 subunits (h2tf1) (oncogene lyt-10) (lyt10) [contains: nuclear factor nf-kappa-b p52 subunit]. [source:swissprot;acc:q00653]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8277.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8210.26\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2662\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj408b20.3 (novel protein similar to 60s acidic ribosomal protein p2 (rplp2)). [source:sptrembl;acc:q9h5a9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4300.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4334.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00795\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2663\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-actin crosslinking factor 1, isoform 4. [source:swissprot;acc:q96pk2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4608.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4576.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00703\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2664\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bullous pemphigoid antigen 1 isoforms 1/2/3/4/5/8 (230 kda bullous pemphigoid antigen) (bpa) (hemidesmosomal plaque protein) (dystonia musculorum protein) (fragment). [source:swissprot;acc:q03001]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4608.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4576.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00702\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2665\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8936.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8999.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.007\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2666\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dyskerin (nucleolar protein nap57) (cbf5 homolog). [source:swissprot;acc:o60832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4591.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4621.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2667\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 7.6 kda polypeptide (ec 2.7.7.6) (rpb10) (rpb7.6) (rpabc5). [source:swissprot;acc:p52436]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4071.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4099.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00666\vspace{3pt}}\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/